We recently demonstrated that Pediococcus acidilactici pA1c counteracts the effects of high-glucose exposure in C. elegans through the insulin signaling pathway [26] and its antidiabetic effect in T2D HFD-induced mice [15]. This evidence concerns the gene INS and type 2 diabetes mellitus.